Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKinsey
Medtronic
Johnson and Johnson
Express Scripts

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Cytochrome P-450 Enzyme Inhibitors

See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global YONSA abiraterone acetate TABLET;ORAL 210308-001 May 22, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
Hikma Pharms ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 208339-001 Oct 31, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 208453-001 Oct 31, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 208446-001 Oct 31, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Wockhardt Bio Ag ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 208380-001 Feb 27, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 208432-001 Oct 31, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Qilu Pharm Co Ltd ABIRATERONE ACETATE abiraterone acetate TABLET;ORAL 212462-001 Sep 27, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Dow
Medtronic
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.